Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 10,000 shares at $16.21 ($162K) on 2015-05-13, disclosed to the SEC on 2016-04-15.
Open-market sale of $162k NXTM by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-03-22 | $83K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |